Delivery Order SPE2DB20D3103-SPE2DB22FM2N8
Award Date
1/11/22
Potential Completion Date
1/12/22
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Tobramycin 300 mg/5 ml ampules. The $3,023.34 firm fixed price contract was issued by the Defense Logistics Agency (DLA) and does not have a set-aside designation.
Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The $3,799.28 firm fixed-price delivery order is for the supply of 4557599789 - Tobramycin 300 mg/4 ml ampules. The contract has no set-aside designation, indicating it was awarded through open competition.
Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,886.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobramycin 300 mg/4 ml ampules, a critical medical commodity used in various therapeutic areas.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,441.22, is for the delivery of Tobramycin 300 mg/4 ml ampules. It is a firm-fixed-price delivery order with a completion date of December 13, 2023. The contract was awarded on December 12, 2023 and does not have a set-aside designation, indicating it was competitively...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $1,258.06 firm fixed price delivery order is for the supply of 4565218417 - TOBRAMYCIN 300 MG/5 ML AMPULE UD 5ML, a pharmaceutical product. The contract has a completion date of July 23, 2024 and was awarded on July 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,392.13 firm fixed-price delivery order is for the supply of 1.2 gram vials of the drug Tobramycin. The contract does not have a set-aside designation.
Amerisourcebergen is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical division....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Tobramycin 300 mg/5 ml ampules. The contract has a potential value of $9,313.23 and a performance period through January 26, 2024.
Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,733.26 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 300 mg/5 mL ampules of tobramycin. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 27, 2023. No set aside designation was applied to this order awarded under the DLA's prime vendor program to provide pharmaceuticals and medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is for the provision of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $83,202.05, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of June 11, 2020.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $11,391.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...